AUKELSO Trademark

Trademark Overview


On Monday, May 6, 2024, a trademark application was filed for AUKELSO with the United States Patent and Trademark Office. The USPTO has given the AUKELSO trademark a serial number of 98535453. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, November 19, 2024. This trademark is owned by Biocon Biologics Limited. The AUKELSO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical, medical and biological preparations for treatment of osteoporosis in postmenopausal women; pharmaceutical, medical and biological preparations for increasing bone mass in men with osteoporosis; pharmaceutical, medical and biological preparations for treatment of glucocorticoid-induced osteoporosis; pharmaceutical, medical and biological preparations for treatment of bone loss in men receiving androgen deprivation therapy for prostate cancer; pharmaceutical, medical and biological preparations for treatment of bone loss in women receiving adjuvant aromatase inhibitor therapy for breast cancer
aukelso

General Information


Serial Number98535453
Word MarkAUKELSO
Filing DateMonday, May 6, 2024
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, November 19, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 19, 2024

Trademark Statements


Goods and ServicesPharmaceutical, medical and biological preparations for treatment of osteoporosis in postmenopausal women; pharmaceutical, medical and biological preparations for increasing bone mass in men with osteoporosis; pharmaceutical, medical and biological preparations for treatment of glucocorticoid-induced osteoporosis; pharmaceutical, medical and biological preparations for treatment of bone loss in men receiving androgen deprivation therapy for prostate cancer; pharmaceutical, medical and biological preparations for treatment of bone loss in women receiving adjuvant aromatase inhibitor therapy for breast cancer

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, May 6, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameBiocon Biologics Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBengaluru, Karnataka 560100
IN

Party NameBiocon Biologics Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBengaluru, Karnataka 560100
IN

Trademark Events


Event DateEvent Description
Monday, May 6, 2024NEW APPLICATION ENTERED
Tuesday, May 7, 2024TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
Tuesday, May 7, 2024TEAS VOLUNTARY AMENDMENT RECEIVED
Tuesday, May 7, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, August 31, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Saturday, August 31, 2024ASSIGNED TO EXAMINER
Saturday, August 31, 2024NON-FINAL ACTION WRITTEN
Saturday, August 31, 2024NON-FINAL ACTION E-MAILED
Tuesday, September 3, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, September 3, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, September 3, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, October 7, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 13, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 19, 2024PUBLISHED FOR OPPOSITION
Tuesday, November 19, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED